Dual sourcing is the standard playbook for tariff mitigation. Qualify a second supplier in a non-China origin country, shift volume, eliminate Section 301 exposure. In most industries, the timeline from decision to first shipment is measured in weeks. In …
Read more
Tag Archives: medical device
Dual sourcing medical device components under QSR: tariff implications of approved supplier constraints
FDA requalification costs and tariff lock-in: when 25% duty is cheaper than switching suppliers
Every procurement director in the medical device sector knows the number: 25%. Section 301 duties on Chinese-origin components have been baked into landed cost models for years now. What most haven’t done is the harder math – comparing cumulative tariff …
Read more
When outsourcing is not the answer
Deciding when outsourcing is right—and when it’s not—can be a major undertaking for medical technology executives. But using a process that models a company’s possible scenarios can help to make even a complex decision simpler.
Read more
1
